awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36257199-A806A9F7-D6EF-4BF7-B15E-402FE1CFDA8B
Q36257199-A806A9F7-D6EF-4BF7-B15E-402FE1CFDA8B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36257199-A806A9F7-D6EF-4BF7-B15E-402FE1CFDA8B
Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes
P2860
Q36257199-A806A9F7-D6EF-4BF7-B15E-402FE1CFDA8B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36257199-A806A9F7-D6EF-4BF7-B15E-402FE1CFDA8B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7f9d30b19a1a94e9f68ade35f9ed1f3c7e253054
P2860
Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data.